Results 111 to 120 of about 5,553,839 (283)

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

open access: yesMolecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts   +8 more
wiley   +1 more source

ЕXAMINING CHEQUES FOR DISTINCTIVE FEATURES OF SECURITIES IN THE CONTEXT OF CRIMINAL CASES REGARDING CHEQUE COUNTERFEITING

open access: yesТеория и практика судебной экспертизы, 2016
The author reviews court rulings related to cheque counterfeiting. It is revealed that recognition of cheques as securities is a controversial and arguable issue.
O. S. Belomyttseva
doaj  

Adenosine‐to‐inosine editing of miR‐200b‐3p is associated with the progression of high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira   +14 more
wiley   +1 more source

De la nécessité d’identifier précisément le décor géométrique d’une mosaïque. Une étude de cas

open access: yesJournal of Mosaic Research, 2016
In published articles, the description of geometric mosaics is generally confined to the Décor’s typology, which is of course indispensable but not always precise enough to identify their geometric properties accurately. However these properties allow an
Bernard PARZYSZ
doaj  

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

open access: yesMolecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian   +10 more
wiley   +1 more source

Integrated genomic and proteomic profiling reveals insights into chemoradiation resistance in cervical cancer

open access: yesMolecular Oncology, EarlyView.
A comprehensive genomic and proteomic analysis of cervical cancer revealed STK11 and STX3 as a potential biomarkers of chemoradiation resistance. Our study demonstrated EGFR as a therapeutic target, paving the way for precision strategies to overcome treatment failure and the DNA repair pathway as a critical mechanism of resistance.
Janani Sambath   +13 more
wiley   +1 more source

Building validation tools for knowledge-based systems [PDF]

open access: yes
The Expert Systems Validation Associate (EVA), a validation system under development at the Lockheed Artificial Intelligence Center for more than a year, provides a wide range of validation tools to check the correctness, consistency and completeness of ...
Chang, C. L.   +3 more
core   +1 more source

YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma

open access: yesMolecular Oncology, EarlyView.
The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy   +9 more
wiley   +1 more source

Check as Form of Municipal Control

open access: yesÈkonomika, Pedagogika i Pravo, 2016
In this article bases of legal regulation of one of forms of municipal control - check are revealed. The overview of tendencies of development of municipal control is given.
Pavel A. Bishkov
doaj  

Home - About - Disclaimer - Privacy